Enfusion’s $367 Million IPO

Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Inventiva’s At-The-Market Offering

Davis Polk advised the sales agent on the deal. Inventiva S.A., a clinical-stage biotechnological company, announced the implementation of an At-The-Market (“ATM”) program allowing the Company to...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here